IRF6 and breast cancer: Concomitantly with this in breast cancer cell lines (MCF-7 and MDA-MD-231) overexpression of IRF6 together with maspin (located cytoplasmically) induced a synergistic effect of inhibition of proliferation but not total inhibition of proliferation [52].